 | Up a level |
2017
Goltz, D., Gevensleben, H., Bootz, F., Kristiansen, G., Dietrich, D. and Landsberg, J. (2017). Prognostic significance of PDCD1 (PD-1), CD274 (PD-L1) and PDCD1LG2 (PDL2) promoter methylation for melanoma patients. Exp. Dermatol., 26 (3). S. E83 - 1. HOBOKEN: WILEY. ISSN 1600-0625
Goltz, D., Gevensleben, H., Kristiansen, G., Vogt, T., Hoffmann, F., Dietrich, D. and Landsberg, J. (2017). Prognostic significance and predictive value to anti-PD1 treatment of promoter methylation of PDCD1 (PD-1), CD274 (PD-L1) and PDCD1LG2 (PD-L2) for melanoma patients. J. Dtsch. Dermatol. Ges., 15. S. 2 - 3. HOBOKEN: WILEY. ISSN 1610-0387
2015
Goltz, D., Huss, S., Ramadori, E., Buettner, R., Diehl, L. and Meyer, R. (2015). Immunomodulation by splenectomy or by FTY720 protects the heart against ischemia reperfusion injury. Clin. Exp. Pharmacol. Physiol., 42 (11). S. 1168 - 1178. HOBOKEN: WILEY-BLACKWELL. ISSN 1440-1681